KINNATE BIOPHARMA INC's ticker is KNTE and the CUSIP is 49705R105. A total of 1 filers reported holding KINNATE BIOPHARMA INC in Q4 2023. The put-call ratio across all filers is - and the average weighting 6.2%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $14,989 | -57.0% | 10,706 | -7.0% | 0.00% | -100.0% |
| Q2 2023 | $34,896 | +174380.0% | 11,517 | +272.2% | 0.00% | 0.0% |
| Q1 2023 | $20 | +400.0% | 3,094 | +349.7% | 0.00% | – |
| Q4 2022 | $4 | -100.0% | 688 | -90.1% | 0.00% | -100.0% |
| Q3 2022 | $83,000 | +245.8% | 6,926 | +263.6% | 0.00% | 0.0% |
| Q2 2022 | $24,000 | +166.7% | 1,905 | +141.8% | 0.00% | – |
| Q1 2022 | $9,000 | -60.9% | 788 | -40.9% | 0.00% | – |
| Q4 2021 | $23,000 | +91.7% | 1,333 | +150.6% | 0.00% | – |
| Q3 2021 | $12,000 | -20.0% | 532 | -17.9% | 0.00% | – |
| Q2 2021 | $15,000 | -25.0% | 648 | -0.3% | 0.00% | – |
| Q1 2021 | $20,000 | – | 650 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Foresite Capital Management V, LLC | 3,525,957 | $4,936,340 | 7.88% |
| Foresite Capital Management IV, LLC | 9,671,643 | $13,540,300 | 7.52% |
| Vida Ventures Advisors, LLC | 2,207,772 | $3,090,881 | 4.78% |
| Lynx1 Capital Management LP | 1,997,006 | $2,795,808 | 1.85% |
| Nextech Invest Ltd. | 2,329,480 | $3,261,272 | 0.99% |
| Orbimed Advisors | 8,009,729 | $11,213,621 | 0.24% |
| Novo Holdings A/S | 815,707 | $1,141,990 | 0.08% |
| DAFNA Capital Management LLC | 105,179 | $147,251 | 0.05% |
| GSA CAPITAL PARTNERS LLP | 374,291 | $524 | 0.04% |
| Rock Springs Capital Management LP | 405,811 | $568,135 | 0.02% |